ViiV Healthcare (GSK) Director, Access Strategy, Portfolio and Pipeline Innovation

ViiV Healthcare is a global specialty HIV company, the only one that is 100% focused on researching and delivering new medicines for people living with, and at risk of, HIV. ViiV is highly mission-driven in our unrelenting commitment to being a trusted partner for all people living with and affected by HIV. Our aim is to think, act, and connect differently through a focus on education on and treatment for HIV.  We go to extraordinary lengths to deliver the sorts of breakthroughs, both in treatments, care solutions and communities, that really count. We go beyond the boundaries of medicine by taking a holistic approach to HIV through developing and supporting sustainable community programs and improving access to care.  We are fully committed to push through every challenge until HIV/AIDS is eradicated. ViiV has played a significant part in delivering breakthroughs that have turned HIV into a manageable health condition. We offer the largest portfolio of HIV medicines available anywhere, and we continue our work to cater for the widest possible range of needs in response to the HIV epidemic.

We are aware of how much is at stake for those affected by HIV and we show up every day 100% committed to the patients. Our work culture is fast-paced, diverse, inclusive, competitive, and caring. But ViiV isn’t just somewhere to work – it’s a place to belong, an invitation to bring your very best, and a team full of impact-driven team members who are hungry to make a difference.

While we have been improving lives of HIV patients for 30 years, this is an especially exciting time to be at ViiV, as we evaluate novel approaches to treatment and prevention that could further reduce the impact of HIV on individuals and communities.

Research Triangle Park | Where People + Ideas Converge (rtp.org)

• →Lead US market access strategy for assigned portfolio and lifecycle priorities, including loss-of-exclusivity, indication expansion, formulation or dosing evolution, and other events that could materially affect access, reimbursement, or portfolio value.
• →Lead the development of the US access strategy for products facing loss-of-exclusivity, integrating payer behavior, channel dynamics, competitor evolution, and implications for the broader ViiV portfolio.
• →Ensure lifecycle strategies consider the interdependencies among oral treatment, long-acting treatment, prevention, emerging competitors, and future ViiV assets.
• →Partner with brand-aligned Access Strategy Directors to ensure that portfolio-level recommendations translate into coordinated product strategies and execution.

• Serve as the US Market Access lead for assigned early- and late-stage pipeline assets, embedding payer, purchaser, provider, channel, and patient-access insights into development and commercialization strategies.
• Define the access ambition, critical success factors, and minimum and aspirational access requirements for pipeline assets in partnership with Global Market Access and US cross-functional stakeholders.
• Shape target product profiles, value propositions, evidence plans, pricing hypotheses, channel strategies, and launch assumptions from a US access perspective.
• Translate emerging long-acting treatment and next-generation PrEP concepts into actionable access hypotheses, including benefit design, site-of-care, acquisition, reimbursement, distribution, and patient-start considerations.

• Establish a structured process to monitor, assess, and communicate external developments that could affect ViiV’s portfolio, including government pricing policy, Medicaid eligibility and financing changes, PBM and payer-model evolution, reimbursement reform, and channel consolidation.
• Translate external policy developments into product-level and portfolio-level implications, including potential effects on access, evidence needs, channel economics, and patient affordability.
• Develop scenario analyses and strategic recommendations for high-impact policy risks in partnership with cross-functional subject-matter experts in Government Relations.
• Provide senior leaders with concise, decision-oriented assessments of major external access developments rather than descriptive policy updates alone.

Please visit GSK US Benefits Summary to learn more about the comprehensive benefits program ViiV offers US employees. All ViiV employees receive the same benefits options and plans as GSK employee.

At ViiV Healthcare, we will not rest until we leave no person living with HIV behind. Until the 40 million people living with HIV is down to zero, we will continue searching for new ways to limit the impact of HIV. 

We are the only pharmaceutical company solely focused on combating, preventing, and ultimately eradicating HIV and AIDS. At ViiV Healthcare, we do things differently. Born out of a partnership between GSK and Pfizer in 2009, with Shionogi joining in 2012, we are determined to help end the HIV epidemic. We are guided by our mission to leave no person living with HIV behind and it is this mission that unites our employees located across the globe. We combine expertise in research, manufacturing, policy and more to push the boundaries of what people think is possible in HIV treatment and care. As a result of our connection with GSK, we are able to draw on their proud history and resources. This means that you would receive all the employee benefits offered by GSK.

Living our mission of leaving no person living with HIV behind means keeping inclusion and diversity at the heart of everything we do - from our breakthrough innovation, to our diverse portfolio of medicines as well as the work we do to partner with HIV communities.

Having a truly inclusive culture where we’re all able to be ourselves and feel like we belong will make us an even stronger team, better able to perform as a business and deliver on our mission to leave no person living with HIV behind.

If you require an accommodation or other assistance to apply for a job at GSK, please contact the appropriate Recruitment Staff by emailing us at - usrecruitment.adjustments@gsk.com

ViiV is an Equal Opportunity Employer. This ensures that all qualified applicants will receive equal consideration for employment without regard to race, color, religion, sex (including pregnancy, gender identity, and sexual orientation), parental status, national origin, age, disability, genetic information (including family medical history), military service or any basis prohibited under federal, state or local law.

ViiV does not accept referrals from employment businesses and/or employment agencies in respect of the vacancies posted on this site. All employment businesses/agencies are required to contact ViiV's commercial and general procurement/human resources department to obtain prior written authorization before referring any candidates to ViiV. The obtaining of prior written authorization is a condition precedent to any agreement (verbal or written) between the employment business/ agency and ViiV. In the absence of such written authorization being obtained any actions undertaken by the employment business/agency shall be deemed to have been performed without the consent or contractual agreement of ViiV. ViiV shall therefore not be liable for any fees arising from such actions or any fees arising from any referrals by employment businesses/agencies in respect of the vacancies posted on this site.

Please note that if you are a US Licensed Healthcare Professional or Healthcare Professional as defined by the laws of the state issuing your license, ViiV may be required to capture and report expenses ViiV incurs, on your behalf, in the event you are afforded an interview for employment. This capture of applicable transfers of value is necessary to ensure ViiV’s compliance to all federal and state US Transparency requirements. For more information, please visit the Centers for Medicare and Medicaid Services (CMS) website at https://openpaymentsdata.cms.gov/